Carbon anhydrase IX specific immune responses in patients with metastatic renal cell carcinoma potentially cured by interleukin-2 based immunotherapy

By Rasmussen Susanne   Donskov Frede   Pedersen Johannes W.   Wandall Hans H.   Buus Søren   Harndahl Mikkel   Braendstrup Peter   Claesson Mogens H.   Pedersen Anders Elm  

Immunopharmacology and Immunotoxicology, Vol. 35, Iss. 4, 2013-08 ,pp. : 487-496

Informa Healthcare

Access to resources Recommend Favorite

A Randomised Controlled Trial of IFN-α, IL-2 and 5FU Versus IFN-α Alone in Metastatic Renal Cell Carcinoma (ISRCTN 46518965)*

By  

UroOncology, Vol. 2, Iss. 2, 2002-01 ,pp. : 51-53

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Epilepsy impairs QOL

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 301, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Lapatinib and renal cell carcinoma

By Gross-Goupil Marine   Bernhard Jean-Christophe   Ravaud Alain  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 11, 2012-11 ,pp. : 1727-1732

Informa Healthcare

Access to resources Recommend Favorite

Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma

By  

Current Molecular Pharmacology, Vol. 9, Iss. 3, 2016-08 ,pp. : 226-230

Bentham Science Publishers

Access to resources Recommend Favorite